Ashkenazi A, Dixit VM. 1999. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11: 255-260.
Bishayee K, Ghosh S, Mukherjee A, Sadhukhan R, Mondal J, Khuda-Bukhsh AR. 2013. Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M in cervical carcinoma: signal cascade and drug-DNA interaction. Cell Prolif. 46: 153-163.
Booher RN, Holman PS, Fattaey A. 1997. Human Myt1 is a cell cycle regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem. 272: 22300-22306.
Chang KL, Kung ML, Chow NH, Su SJ. 2004. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem. Pharmacol. 67: 717-726.
Cory S, Adams JM. 2002. The Bcl2 family: regulators of the cellular life or death switch. Nat. Rev. Cancer 2: 647-656.
Cui JC, Cui Y, Huang MH, Kim HJ, Jin CY, Park C, 2010. Apoptosis induction of human leukemia U937 cells by water extract of wild Ganoderma lucidum spores. Caner Prev. Res. 15: 347-357.
Donzelli M, Draetta GF. 2003. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Reports 4: 671-677.
Dorai T, Aggarwal BB. 2004. Role of chemopreventive agents in cancer therapy. Cancer Lett. 215: 129-140.
Elledge SJ, Harper JW. 1994. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6: 847852.
Fulda S, Debatin KM. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811.
Gupta S. 2003. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int. J. Oncol. 22: 15-20.
Hartwell LH, Kastan MB. 1994. Cell cycle control and cancer. Science 266: 1821-1828.
Hartwell LH, Weinert TA. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-633.
Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407: 770-776.
Hong SH, Choi YH. 2012. Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells. Oncol. Rep. 27: 114-120.
Hsieh WT, Huang KY, Lin HY, Chung JG. 2006. Physalis angulate induced G2/M phase arrest in human breast cancer cells. Food Chem. Toxicol. 44: 974-983.
Jin KS, Oh YN, Lee JY, Son BY, Choi WB, Lee EW, et al. 2013. Anti-oxidative and anti-inflammatory activities of seven medicinal herbs including Tetrapanax papyriferus and Piper longum Linne. Korean J. Microbiol. Biotechnol. 41: 253-262.
Jin P, Gu Y, Morgan DO. 1996. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134: 963-970.
Kawabe T. 2004. G2 checkpoint abrogators as an anticancer drugs. Mol. Cancer Ther. 3: 513-519.
Khan N, Adhami VM, Mukhtar H. 2008. Apoptosis by dietary agents for prevention and treatment of cancer. Biochem. Pharmacol. 76: 1333-1339.
Lee BC, Park HM, Sim HS, Kim GS, Gu JH, Oh MJ. 2009. Biological activity and chemical analysis of Cattail Pollens. J. Agri. Sci. 36: 185-197.
Lee H, Kang R, Yoon Y. 2010. SH21B, an anti-obesity herbal composition, inhibits fat accumulation in 3T3-L1 adipocytes and high fat diet-induced obese mice through the modulation of the adipogenesis pathway. J. Ethnopharmacol. 127: 709-717.
Lee SM, Kwon JI, Choi YH, Eom HS, Chi GY. 2008. Induction of G2/M arrest and apoptosis by water extract of Stychni semen in human gastric carcinoma AGS cells. Phytother. Res. 22: 752-758.
McGowan CH, Russell P. 1993. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr 15. EMBO J. 12: 75-85.
Meiler J, Schuler M. 2006. Therapeutic targeting of apoptotic pathways in cancer. Curr. Drug. Targets 7: 1361-1369.
Neergheen VS, Bahorun T, Taylor EW, Jen LS, Aruoma OI. 2010. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 278: 229-241.
Nicholson DW, Thornberry NA. 1997. Caspase: killer proteases. Trends Biochem. Sci. 22: 299-306.
O’Connor PM. 1997. Mammalian G1 and G2 phase checkpoints. Cancer Surv. 29: 151-182.
Ryan KM, Phillips AC, Vousden KH. 2001. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13: 332-337.
Schreiber V, Dantzer F, Ame JC, de Murcia G. 2006. Poly (ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7: 517-528.
Taylor WR, Stark GR. 2001. Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815.
Vermeulen K, Van Bockstaele DR, Berneman ZN. 2003. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36: 131-149.
Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408: 307-310.
Wang ZY, Wang DM, Loo TY, Cheng Y, Chen LL, Shen JG, et al. 2011. Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint. J. Ethnopharmacol. 133: 751-758.
Xin H, Kong Y, Wang Y, Zhou Y, Hu Y, Li D, et al. 2013. Lignans extracted from Vitex negundo possess cytotoxic activity by G2/M phase cell cycle arrest and apoptosis induction. Phytomedicine 20: 640-647.
Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
Zhou BB, Elledge SJ. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408: 433-439.